In addition to aromatase expression increasing in ASCs from obese individuals, it has also been suggested that the number of ASCs within the breast increases as adipose tissue expands in obesity, further compounding the elevation in aromatase levels and consequently, estrogen levels in postmenopausal breast tissue (29–32). This evidence concerns the gene CYP19A1 and obesity due to melanocortin 4 receptor deficiency.